phentermineteratogenicitytopiramateweight lossEffective treatment of obesity could reduce the burden of diseases primarily driven by excess body weight (e.g., Type 2 diabetes). At present, effective nonsurgical weight management tools are scarce. This paper reviews the investigational combination of ...
Qsymia, an extended-release medicine that contains phentermine and topiramate, is FDA approved for weight loss, along with diet and exercise. Continue reading Does topiramate cause hair loss? Yes, topiramate has been shown to cause hair loss in studies, but it is not a common side effect. ...
Qsymia (Phentermine and Topiramate) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources.
This paper reviews the investigational combination of phentermine, a weight-loss drug available for over half a century, and topiramate, an antiepileptic drug with known weight-loss effects, as a proposed anti-obesity intervention. The combination therapy achieves weight loss of a magnitude that ...
Qsymia (phentermine/topiramate) - Uses, Side Effects, and More Medically Reviewed by Laurel Riemann, PharmD on Sep 17, 2024 | Written by Michelle Vermeulen, PharmD Common Brand Name(s): Qsymia Common Generic Name(s): phentermine/topiramate Pronunciation: Kyoo-sim-ee-uh Drug Classes: appetite...
OBJECTIVE: To review the pharmacology, efficacy, and safety of phentermine/topiramate (PHEN/TPM) in the management of obese patients.DATA SOURCES: MEDLINE (1966-July 2012) was searched using the terms weight loss, obesity, phentermine and topiramate, phentermine, topiramate, Qnexa, Qsymia, and VI...
It is one of the three dietary monosaccharaides along with glucose and galactose. Like glucose, excess intake of fructose gives rise to metabolic syndrome. Fructose derivatives used as weight-loss drugs are relatively rare. From 2010 to 2018, one entity (topiramate, combined with phentermine) ...
被引量: 0发表: 2005年 Pharmacotherapy for Obesity Recently FDA approved two new drugs for the treatment of obesity: the first one was lorcaserin and the second one was phentermine/topiramate extended-relea... G Derosa,P Maffioli - Springer New York 被引量: 0发表: 2014年 加载更多来源...
A method for effecting weight loss by administering a combination of topiramate and phentermine is provided. The phentermine is generally administered in immediate release form, in a daily dose in the range of 2 mg to 8 mg, in combination with a daily dose of topiramate selected to prevent the...
(below; see under phentermine, p. 2329.2, for details of doses). for both adjunctive and monotherapy of epilepsy, the initial oral dose of topiramate is 25 to 50 mg at night for 1 week increased thereafter by increments of 25 or 50 mg at intervals of 1 to 2 weeks until the effective...